Rituximab in the management of retroperitoneal fibrosis: A single tertiary rheumatology care center experience.
Mert ÖztaşIzzet AltunAli Yagiz AylaEmir CermeÇetin DemirdağSertaç AsaKerim SonmezogluSerdal UğurluPublished in: International journal of rheumatic diseases (2023)
Our study shows that rituximab may be a favorable treatment option for glucocorticoid-refractory RPF patients with high disease activity on PET-CT scans.
Keyphrases
- pet ct
- disease activity
- rheumatoid arthritis
- systemic lupus erythematosus
- juvenile idiopathic arthritis
- diffuse large b cell lymphoma
- rheumatoid arthritis patients
- ankylosing spondylitis
- healthcare
- computed tomography
- positron emission tomography
- hodgkin lymphoma
- palliative care
- chronic lymphocytic leukemia
- magnetic resonance imaging
- magnetic resonance